EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients

Homin Kang iD, Jungyo Suh iD, Dalsan You iD, In Gab Jeong iD, Bumsik Hong iD, Jun Hyuk Hong iD, Hanjong Ahn iD, Bumjin Lim iD

Investigative and Clinical Urology · 2024

DOI: 10.4111/icu.20230389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative and Clinical Urology, 2024. Verfasst von Homin Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cisplatin, Gemcitabine, Deoxycytidine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCisplatinGemcitabineDeoxycytidineNeoadjuvant TherapyNeoplasm InvasivenessAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleAgedRisk FactorsMiddle AgedRetrospective StudiesTreatment FailureCystectomyChemotherapy, Adjuvant

Stichwörter der Autor:innen

Diabetes mellitusNeoadjuvant chemotherapyRadical cystectomyUrinary bladder cancer

Substanzen

CisplatinGemcitabineDeoxycytidine

Autor:innen und Institutionen

  • Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. lbj1986@hanmail.net.

ORCID-Profile: Homin Kang, Jungyo Suh, Dalsan You, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Bumjin Lim

Zitieren

APA

Kang, H., Suh, J., You, D., Jeong, I. G., Hong, B., Hong, J. H., Ahn, H., & Lim, B. (2024). Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20230389

Vancouver

Kang H, Suh J, You D, Jeong IG, Hong B, Hong JH, et al. Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients. Investigative and Clinical Urology. 2024. doi:10.4111/icu.20230389

BibTeX
@article{Kang2024,
  author = {Kang, Homin and Suh, Jungyo and You, Dalsan and Jeong, In Gab and Hong, Bumsik and Hong, Jun Hyuk and Ahn, Hanjong and Lim, Bumjin},
  title = {Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients},
  journal = {Investigative and Clinical Urology},
  year = {2024},
  doi = {10.4111/icu.20230389}
}
Kostenlos starten →